{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:52:36Z","timestamp":1786989156892,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2094,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.fertnstert.2016.04.024","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T11:50:29Z","timestamp":1462881029000},"page":"584-589.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?"],"prefix":"10.1016","volume":"106","author":[{"given":"Matthew T.","family":"Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Patounakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mae Wu","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan H.","family":"DeCherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Widra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3104-7763","authenticated-orcid":false,"given":"Micah J.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.04.024_bib1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.rbmo.2012.01.010","article-title":"Elevated progesterone during ovarian stimulation for IVF","volume":"24","author":"Al-Azemi","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib2","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.fertnstert.2015.02.038","article-title":"Are good patient and embryo characteristics protective against the negative effects of elevated progesterone level on the day of oocyte maturation?","volume":"103","author":"Hill","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0015-0282(99)00524-5","article-title":"Prospective, randomized, controlled study of in\u00a0vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)","volume":"73","author":"Olivennes","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0015-0282(01)01973-2","volume":"76","author":"Westergaard","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10815-011-9585-x","article-title":"\u201cPremature luteinization\u201d in the era of GnRH analogue protocols: time to reconsider","volume":"28","author":"Younis","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.rbmo.2010.05.018","article-title":"The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles","volume":"21","author":"Fleming","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.fertnstert.2006.12.064","article-title":"Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer","volume":"91","author":"Papanikolaou","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.fertnstert.2012.04.041","article-title":"Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower liver birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers","volume":"98","author":"Ochsenk\u00fchn","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib9","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1093\/humrep\/deq125","article-title":"Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in\u00a0vitro fertilization: analysis of over 4000 cycles","volume":"25","author":"Bosch","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0015-0282(16)54186-7","article-title":"Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate","volume":"55","author":"Schoolcraft","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0015-0282(16)56584-4","article-title":"Elevated serum progesterone levels on the day of human chorionic-gonadotropin administration in in-vitro fertilization cycles do not adversely affect embryo quality","volume":"61","author":"Silverberg","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","article-title":"Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in\u00a0vitro fertilization outcome","volume":"80","author":"Bosch","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib13","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/oxfordjournals.humrep.a135864","article-title":"Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone","volume":"10","author":"Ubaldi","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1472-6483(10)60514-7","article-title":"Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles","volume":"8","author":"Martinez","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/humupd\/dmm007","article-title":"Is Progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in\u00a0vitro fertilization? A systematic review and meta-analysis","volume":"13","author":"Venetisi","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00404-011-2045-0","article-title":"Elevated progesterone in GnRH agonist down regulated in\u00a0vitro fertilization (IVFICSI) cycles reduces live birth rates but not embryo quality","volume":"285","author":"Lahoud","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2174\/138920112799361927","article-title":"Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis","volume":"13","author":"Kolibianakis","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.fertnstert.2015.01.034","article-title":"Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches","volume":"103","author":"Humaiden","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib19","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1210\/jc.2002-021953","volume":"88","author":"Beckers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib20","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.fertnstert.2006.05.049","article-title":"Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates","volume":"86","author":"Acevedo","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.fertnstert.2015.09.008","article-title":"Should progesterone on the human chorionic gonadotropin day still be measured?","volume":"105","author":"Martinez","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib22","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.fertnstert.2008.09.023","article-title":"Elective single embryo transfer: a 6-year progressive implementation of 784 single blastocyst transfers and the influence of payment method on patient choice","volume":"92","author":"Stillman","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10815-013-9932-1","article-title":"The simplified SART embryo scoring system is highly correlated to implantation and live birth in single blastocyst transfers","volume":"30","author":"Heitmann","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.fertnstert.2013.05.028","article-title":"Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulation hormone-gonadotropin-releasing hormone antagonist in\u00a0vitro fertilization cycles","volume":"100","author":"Fatemi","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib25","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/humrep\/der126","article-title":"Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomcis analysis","volume":"26","author":"Labarta","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.fertnstert.2015.09.015","article-title":"Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles?","volume":"105","author":"Healy","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.04.024_bib27","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.fertnstert.2014.02.037","article-title":"Precision of progesterone measurements with the use of automated immunoassay analyzers and the impact on clinical decisions for in\u00a0vitro fertilization","volume":"101","author":"Patton","year":"2014","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216611160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216611160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T02:08:00Z","timestamp":1666490880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216611160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0015028216611160"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.04.024","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger?","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a92016 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine","name":"copyright","label":"Copyright"}]}}